Yuyu Pharma (000220) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma (000220) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yuyu Pharma (000220) net asset quality to measure how much of total assets are equity-financed.

Yuyu Pharma - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yuyu Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yuyu Pharma cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Yuyu Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suparma Tbk JK:SPMA	0.049x
KCP Sugar and Industries Corporation Limited NSE:KCPSUGIND	0.087x
Acanthe Développement PA:ACAN	-0.049x
Alchera Inc. KQ:347860	-0.076x
Eastern Star Real Estate Public Company Limited BK:ESTAR	-0.003x
Yotta Acquisition Corporation Common Stock NASDAQ:YOTA	-0.116x
Wooshin System KO:017370	-0.050x
KLX Energy Services Holdings Inc NASDAQ:KLXE	-0.224x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Yuyu Pharma.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	+277.82%
2013-12-31	₩72.28 Billion ≈ $48.98 Million	₩-775.17 Million ≈ $-525.32K	-0.011x	-111.45%
2012-12-31	₩69.50 Billion ≈ $47.10 Million	₩6.51 Billion ≈ $4.41 Million	0.094x	-5.64%
2011-12-31	₩67.23 Billion ≈ $45.56 Million	₩6.67 Billion ≈ $4.52 Million	0.099x	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$39.15 Million

₩57.77 Billion KRW

Market Cap Rank

#22765 Global

#1451 in Korea

Share Price

₩3570.00

Change (1 day)

+1.71%

52-Week Range

₩3435.00 - ₩4740.00

All Time High

₩16106.03